Improvement seen in quality of life and reduction in specific symptoms for adolescent and young adult breast cancer survivors.

Nurse Pretti, 37, spent his workdays as an intensive care unit nurse at the Department of Veterans Affairs in Minneapolis. He was protesting the presence of ICE agents, who have become an ominous ...

In this study, researchers matched patients using GLP-1RA therapy to those using aspirin to compare colorectal cancer incidence in each population.

Using PROTECT trial data, investigators assessed the possible benefit of early treatment vs active monitoring for cribriform-positive prostate cancer.

After adjustment for other factors, a CFS of 3 or higher and relapsed/refractory disease were the only independent predictors of early zanubrutinib discontinuation.

The FDA's Fast Track designation helps to accelerate the development and review of products for serious and life-threatening conditions. The Food and Drug Administration (FDA) has granted Fast Track ...

Elevated pretreatment levels of LDH and GGT were prognostic for shorter OS in patients with mUM; low albumin, elevated LDH and ALT for shorter TTCS.

Diagnostic evaluation should follow principle of 'as low as reasonably achievable'; systemic therapy should be deferred until second trimester.

Researchers sought to determine whether zanubrutinib combined with rituximab and lenalidomide would improve remission rates in older adults with newly diagnosed DLBCL.

Gathering first-degree family histories for patients with childhood cancers through currently available questions and a personal history is sufficient to ...

In this study from ASCO GI 2026, researchers presented a 4-year follow-up of the phase 3 CheckMate 9DW trial of nivolumab plus ipilimumab in treatment-naïve HCC.

In this study, researchers aimed to characterize cardiometabolic risk factors and cardiovascular disease incidence in ...